Acumen Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on March 28, 2022
March 16 2022 - 4:15PM
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage
biopharmaceutical company focused on the development of novel
targeted therapeutics for Alzheimer’s disease (AD), today announced
that the company will report its financial results for the fourth
quarter and full year 2021 on Monday, March 28, 2022. The company
will host a conference call and live audio webcast at 4:30 p.m. ET
to provide a business and financial update.
Acumen will host a conference call and live audio webcast on
Monday, March 28, at 4:30 pm ET. The live webcast may be accessed
from the Investors section of the Company's website at
www.acumenpharm.com. Please connect to the website prior to the
start of the conference call to ensure adequate time for any
software downloads that may be necessary. Investors may participate
in the conference call by dialing +1 877 311-0573 in the U.S., or
+1 470 495-9505 outside the U.S., and entering passcode
3629669.
An archived version of the webcast will be available for at
least 30 days in the Investors section of the Company's website at
www.acumenpharm.com.
About Acumen Pharmaceuticals, Inc.Acumen,
headquartered in Charlottesville, VA, with clinical operations
based in Carmel, IN, is a clinical stage biopharmaceutical company
developing a novel disease-modifying approach to treat Alzheimer’s
disease. Acumen’s scientific founders pioneered research on AβOs,
which a growing body of evidence indicates are primary triggers of
Alzheimer’s disease pathology. Acumen is currently focused on
advancing its investigational immunotherapy drug, ACU193, a
humanized monoclonal antibody that selectively targets toxic AβOs
in INTERCEPT-AD, a Phase I clinical trial involving early
Alzheimer’s disease patients. For more information, visit
www.acumenpharm.com.
Contacts:
Media:AcumenPR@westwicke.com
Investors:investors@acumenpharm.com
Acumen Pharmaceuticals (NASDAQ:ABOS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Acumen Pharmaceuticals (NASDAQ:ABOS)
Historical Stock Chart
From Jul 2023 to Jul 2024